AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SERTRALINE HYDROCHLORIDE
4 registrations across 4 African markets— 3 active
Markets with SERTRALINE HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ZOSERT 50MG TABLETS Tablet | 🇰🇪Kenya | Sun Pharmaceutical Industries Limited | active | Jul 2031 |
| CP-SERTRALINE 50 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | COSPHARM PHARMACEUTICALS | active | Mar 2030 |
| Serta Cream Cream Topical | 🇿🇲Zambia | Mankind Pharma Ltd | active | Aug 2026 |
| ASPEN SERTRALINE 100 mg | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
SERTRALINE HYDROCHLORIDE in Africa — Regulatory Overview
SERTRALINE HYDROCHLORIDE is registered across 4 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, South Africa, Zambia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.